Zim (ZIMCF) EV-to-OCF: 0.04 (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Zim EV-to-OCF?

Zim ZIMCF EV-to-OCF is 0.04 as of Jul. 31, 2026.

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Zim's Enterprise Value is $0.00 Mil. Zim's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2021 was $0.02 Mil. Therefore, Zim's EV-to-OCF for today is 0.04.

The historical rank and industry rank for Zim's EV-to-OCF or its related term are showing as below:

ZIMCF' s EV-to-OCF Range Over the Past 10 Years
Min: 0.04   Med: 0   Max: 0.04
Current: 0.04

During the past 13 years, the highest EV-to-OCF of Zim was 0.04. The lowest was 0.04. And the median was .

ZIMCF's EV-to-OCF is not ranked
in the Biotechnology industry.
Industry Median: -3.345 vs ZIMCF: 0.04

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-31), Zim's stock price is $0.0002. Zim's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 was $0.034. Therefore, Zim's PE Ratio (TTM) for today is 0.01.


Zim  (OTCPK:ZIMCF) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Zim's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0002/0.034
=0.01

Zim's share price for today is $0.0002.
Zim's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.034.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Zim EV-to-OCF Related Terms


Zim EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Zim's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zim EV-to-OCF Chart

Zim Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21
EV-to-OCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.69 17.40 -2.36 -0.54 -2.70

Zim Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ZIMCF vs MAPT, FSSN, TGHI: EV-to-OCF Comparison

For the Biotechnology subindustry, Zim's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zim EV-to-OCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zim's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Zim's EV-to-OCF falls into.



Zim EV-to-OCF Calculation

Zim's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=0.001/0.024
=0.04

Zim's current Enterprise Value is $0.00 Mil.
Zim's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-OCF →
What does a EV-to-OCF of 0.04 mean?
Zim (ZIMCF) has a EV-to-OCF of 0.04 as of Jul. 31, 2026. Over the past decade, Zim's EV-to-OCF has ranged from 0.04 to 0.04.
Is Zim's EV-to-OCF too high?
Zim's current EV-to-OCF is 0.04. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 0.04.
How does Zim's EV-to-OCF compare to MAPT and FSSN?
Zim's EV-to-OCF of 0.04 can be compared against companies in the Biotechnology industry. Historically, Zim's own EV-to-OCF has ranged from 0.04 to 0.04 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Zim's current EV-to-OCF is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zim stock overvalued right now?
Zim (ZIMCF) has a current EV-to-OCF of 0.04. The current EV-to-OCF is 0.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Zim (ZIMCF), the current EV-to-OCF is 0.04 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zim Business Description

Address 20 Colonade Road, Suite 200, Ottawa, ON, CAN, K2E 7M2
Zim Corp has sold its operations and is currently focused on biomedical research. The company focused all of its resources on developing intellectual property and advancing research and development in the areas of new synthetic drugs and immunotherapies. It generates geographic revenue from Canada.